Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

Item
http://www.wikidata.org/entity/Q38383351
Drug Modulators of B Cell Signaling Pathways and Epstein-Barr Virus Lytic Activation.Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients.Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience.Posttransplant Lymphoproliferative Disease Presenting as an Extracranial Mass.Decreased survival in hepatitis C patients with monomorphic post-transplant lymphoproliferative disorder after liver transplantation treated with frontline immunochemotherapy.Comprehensive review of post-organ transplant hematologic cancers.A retrospective analysis of post-transplant lymphoproliferative disorder following liver transplantation.Posttransplant Lymphoproliferative Disorder After Clinical Islet Transplantation: Report of the First Two Cases.Posttransplant Lymphoproliferative Disorder Isolated to the Adrenal Gland in a Liver Transplant Patient.Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture.Post-transplantation lymphoproliferative disorder with gastrointestinal involvement.
P2860

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

Item
http://www.wikidata.org/entity/Q38383351
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Response to Rituximab Inductio ...... e, Multicenter Phase II Trial.
@en
type
label
Response to Rituximab Inductio ...... e, Multicenter Phase II Trial.
@en
prefLabel
Response to Rituximab Inductio ...... e, Multicenter Phase II Trial.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Response to Rituximab Inductio ...... ve, Multicenter Phase II Trial
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921